VIIV HEALTHCARE PTY LTD

πŸ‡¦πŸ‡ΊAustralia
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects

First Posted Date
2011-10-10
Last Posted Date
2018-01-16
Lead Sponsor
ViiV Healthcare
Target Recruit Count
488
Registration Number
NCT01449929
Locations
πŸ‡¨πŸ‡­

GSK Investigational Site, Zurich, Switzerland

Drug Interaction Study Between Dolutegravir and Prednisone

First Posted Date
2011-08-29
Last Posted Date
2011-11-06
Lead Sponsor
ViiV Healthcare
Target Recruit Count
12
Registration Number
NCT01425099
Locations
πŸ‡ΊπŸ‡Έ

GSK Investigational Site, Buffalo, New York, United States

HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections

First Posted Date
2011-06-29
Last Posted Date
2018-11-14
Lead Sponsor
ViiV Healthcare
Target Recruit Count
254
Registration Number
NCT01384734
Locations
πŸ‡ͺπŸ‡Έ

GSK Investigational Site, Madrid, Spain

Relative Bioavailability Study of a Pediatric Granule Formulation of Dolutegravir

First Posted Date
2011-06-27
Last Posted Date
2011-09-19
Lead Sponsor
ViiV Healthcare
Target Recruit Count
20
Registration Number
NCT01382238
Locations
πŸ‡ΊπŸ‡Έ

GSK Investigational Site, Austin, Texas, United States

Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets

First Posted Date
2011-06-06
Last Posted Date
2011-08-08
Lead Sponsor
ViiV Healthcare
Target Recruit Count
18
Registration Number
NCT01366547
Locations
πŸ‡ΊπŸ‡Έ

GSK Investigational Site, Buffalo, New York, United States

Dolutegravir Renal Impairment Study

First Posted Date
2011-05-16
Last Posted Date
2012-04-30
Lead Sponsor
ViiV Healthcare
Target Recruit Count
16
Registration Number
NCT01353716
Locations
πŸ‡ΊπŸ‡Έ

GSK Investigational Site, Minneapolis, Minnesota, United States

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1

First Posted Date
2011-05-02
Last Posted Date
2016-01-14
Lead Sponsor
ViiV Healthcare
Target Recruit Count
813
Registration Number
NCT01345630
Locations
πŸ‡ΊπŸ‡Έ

Circle CARE Center, Norwalk, Connecticut, United States

πŸ‡«πŸ‡·

CHU de Nantes - Hotel Dieu, Nantes, France

πŸ‡ΊπŸ‡Έ

Health Services Center, Hobson City, Alabama, United States

and more 171 locations

HIV Cohort Study At Johns Hopkins University, University of North Carolina at Chapel Hill and Vanderbilt University

Completed
Conditions
AIDS
HIV
First Posted Date
2011-04-20
Last Posted Date
2014-04-21
Lead Sponsor
ViiV Healthcare
Target Recruit Count
8202
Registration Number
NCT01339416

Kaiser Permanente HIV Cohort Study

Completed
Conditions
AIDS
HIV
Interventions
Other: non-interventional trial
First Posted Date
2011-04-20
Last Posted Date
2015-04-03
Lead Sponsor
ViiV Healthcare
Target Recruit Count
282368
Registration Number
NCT01339403

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects

Phase 1
Completed
Conditions
Infection, Human Immunodeficiency Virus
Interventions
Drug: GSK1349572
First Posted Date
2011-04-11
Last Posted Date
2011-06-27
Lead Sponsor
ViiV Healthcare
Target Recruit Count
10
Registration Number
NCT01332565
Locations
πŸ‡ΊπŸ‡Έ

GSK Investigational Site, Cypress, California, United States

Β© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy